OFFICIAL LEGAL TITLE
Maintaining Investments in New Innovation Act
FREQUENTLY ASKED QUESTIONS
What is the official ID of this bill?
The official print number for this legislation is 118_HR_5547.
Which chamber initiated this legislation?
This legislation was initiated in the House of Representatives.
When did the legislative process begin?
The process officially started on 2023-09-18.
What are the main provisions?
Key points include:
- Extends market protection for genetic drugs from 7 to 11 years.
- Defines "advanced drug product" to include drugs using genetically targeted technologies.
- May accelerate access to new treatments for individuals with genetic diseases.
What is the specific legal status?
The current status is Expired.
Where can I read the full text of this legislation?
The full official text is available at:
View full text
Who is the primary sponsor?
The primary sponsor is Rep. Nickel, Wiley [D-NC-13].
What is the latest detailed status?
The latest detailed status is: Referred to the Subcommittee on Health.
Is this summary verified?
Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-25.